end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AccruedLiabilitiesCurrentAndNoncurrent,AccruedProfessionalFeesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AmortizationOfFinancingCosts,Assets,AssetsCurrent,AssetsHeldInTrustNoncurrent,Cash,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashEquivalentsAtCarryingValue,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,DebtInstrumentFaceAmount,DeferredCosts,DeferredIncomeTaxesAndTaxCredits,DeferredIncomeTaxLiabilitiesNet,DeferredTaxAssetsGross,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsValuationAllowance,DividendsCommonStockCash,DueToRelatedPartiesCurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet,ForeignCurrencyTransactionGainLossBeforeTax,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeTaxExpenseBenefit,IncomeTaxesPaid,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInAccruedIncomeTaxesPayable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInDueToRelatedPartiesCurrent,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncreaseDecreaseInPrepaidExpense,InterestBearingDepositsInBanks,InterestCostsCapitalized,InterestIncomeExpenseNet,InterestPaidNet,InvestmentIncomeInterest,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermNotesPayable,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NotesPayableCurrent,NotesPayableRelatedPartiesClassifiedCurrent,OperatingExpenses,OperatingIncomeLoss,OperatingLossCarryforwards,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,OtherNonoperatingIncomeExpense,OtherUnderwritingExpense,PaymentOfFinancingAndStockIssuanceCosts,PaymentsOfDividendsCommonStock,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,PrepaidExpenseCurrent,PrepaidInsurance,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromIssuanceOrSaleOfEquity,ProceedsFromNotesPayable,ProceedsFromRelatedPartyDebt,ProceedsFromStockOptionsExercised,ProceedsFromWarrantExercises,ProfitLoss,PropertyPlantAndEquipmentNet,RelatedPartyTransactionAmountsOfTransaction,RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty,RepaymentsOfNotesPayable,RepaymentsOfRelatedPartyDebt,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,SaleOfStockNumberOfSharesIssuedInTransaction,SaleOfStockPricePerShare,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares,SharePrice,SharesIssuedPricePerShare,StockholdersEquity,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodValueAcquisitions,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TaxesPayableCurrent,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityRedemptionPricePerShare,TemporaryEquitySharesOutstanding,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,AccountsPayableOtherCurrent,AccountsPayableTradeCurrent,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,CapitalExpendituresIncurredButNotYetPaid,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights,CurrentFederalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,CurrentStateAndLocalTaxExpenseBenefit,DebtInstrumentInterestRateStatedPercentage,DeferredFederalIncomeTaxExpenseBenefit,DeferredForeignIncomeTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredIncomeTaxLiabilities,DeferredStateAndLocalIncomeTaxExpenseBenefit,DeferredTaxAssetsNet,DeferredTaxAssetsOther,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxLiabilities,DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains,DefinedContributionPlanEmployerDiscretionaryContributionAmount,DefinedContributionPlanEmployerMatchingContributionPercent,DefinedContributionPlanEmployerMatchingContributionPercentOfMatch,EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxReconciliationNondeductibleExpense,IncomeTaxReconciliationStateAndLocalIncomeTaxes,ProceedsFromIssuanceOfWarrants,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum,StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
2020-06-30,2020-08-20,10-Q,POINT BIOPHARMA GLOBAL INC.,PNT,CIK0001811764,USD,6108.0,227403.0,33910.0,,24661.0,554888.0,,,514142.0,64690.0,,64690.0,,7046396.0,64690.0,,,,,,,,,449452.0,,,,,,,,,-0.07,,,,,,,,0.0,92919.0,1067333.0,-3133736.0,58261.0,,,,1363.0,,,,,,,,,,,,,,514142.0,508511.0,,82696.0,,-18006.0,-3191997.0,,275000.0,3226655.0,-3226655.0,,,,92919.0,,,,217304.0,,0.0001,1000000.0,,0.0,,,,25000.0,,,,275000.0,,,-19369.0,,677362.0,,,,2159322.0,-19369.0,,,,,,,,10.0,,5631.0,7684750.0,1.0,,8009321.0,,,,,,0.0,0.0,,45362014.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2020-09-30,2020-11-02,10-Q,POINT BIOPHARMA GLOBAL INC.,PNT,CIK0001811764,USD,5186.0,46548.0,,,5184241.0,403997.0,2526320.0,2507.0,136968118.0,1265144.0,135702974.0,1141327.0,0.0,18770254.0,,,,,,,,,,,,,,,,,,-0.06,,-0.06,,,,,0.0,0.0,0.0,31485.0,596164.0,-3047250.0,0.0,,,,,,,,,,,,,25462.0,-2507.0,,2974.0,4801234.0,136968118.0,51734.0,,,,,-3047250.0,,,3076228.0,-3076228.0,,,,28978.0,,,,324555.0,,,1000000.0,,0.0,,123817.0,,,,,,,,,,,47375.0,,,,2480064.0,-184708.0,,,,0.0,0.0065,,,10.0,,5000004.0,18889442.0,,,11321625.0,,,127166880.0,10.0,12716688.0,0.0,0.0,54181325.0,,54181325.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2020-12-31,2021-03-04,10-K,POINT BIOPHARMA GLOBAL INC.,PNT,CIK0001811764,USD,3596634.0,1479041.0,,210099.0,26857040.0,1760806.0,2526320.0,5354.0,22194495.0,12397095.0,135706395.0,1094556.0,10546749.0,10546749.0,,10546749.0,1100000.0,0.0001,430000000.0,54647656.0,54647656.0,5465.0,,,0.0,0.0,3414891.0,1910665.0,3414891.0,0.0,,-0.34,,-0.34,0.21,,,1433785.0,0.0,0.0,0.0,-164962.0,3972649.0,-13285121.0,87882.0,0.0,3412396.0,-2789875.0,,,3596634.0,87882.0,1479041.0,-10400.0,1849170.0,,,54605.0,-5354.0,25462.0,,8714217.0,22194495.0,5163557.0,3550660.0,28647005.0,-9797400.0,-8302856.0,-13373003.0,,,13114805.0,-13114805.0,100000.0,130656.0,27633.0,-170316.0,,,0.0,324555.0,9797400.0,,1000000.0,0.0,0.0,1850346.0,106316.0,0.0,,,25426254.0,3545306.0,,,,-13373003.0,9797400.0,1386878.0,,0.0,,9142156.0,-13382227.0,,10.0,1760806.0,0.0,0.65,,,10.0,,5000009.0,13480278.0,,,22575379.0,,87882.0,127040070.0,10.0,12704007.0,0.0,0.0,38875643.0,,38875643.0,889.0,3595745.0,1760806.0,5233809.0,0.0,25.0,,10000.0,73768.0,87882.0,4114.0,,0.0,0.0,0.0,0.0,0.0,0.0,55889.0,422280.0,45110.0,0.0,0.0,2787.0,,,0.0,-13591329.0,306208.0,39407.0,-574046.0,,,,,2526320.0,
2021-03-31,2021-04-29,10-Q,POINT BIOPHARMA GLOBAL INC.,PNT,CIK0001811764,USD,352744.0,754809.0,,,6710075.0,477245.0,,,136498092.0,788351.0,135709741.0,699534.0,700000.0,699534.0,-395022.0,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,,,,,,,,347635.0,,,,642230.0,,,-17499.0,700000.0,,,,3346.0,5857053.0,136498092.0,5857053.0,,,,-395022.0,-5784421.0,,,,-1402386.0,,,,,,,,,,,1000000.0,,0.0,,88817.0,,,,,,,,,-1399040.0,,,,,,,-1710553.0,,,,,,,,10.0,,5000009.0,28623102.0,1.0,,,450000.0,,125641030.0,10.0,12564103.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-13,10-Q,POINT BIOPHARMA GLOBAL INC.,PNT,CIK0001811764,USD,5018089.0,3145807.0,33910.0,280092.0,313452616.0,1106457.0,,,297462629.0,281808406.0,,,273736820.0,273736820.0,,,,0.001,430000000.0,90121794.0,90121794.0,9012.0,,,,62719.0,,,,,0.0,,-0.15,,,,,1118674.0,,,,-27599.0,1949552.0,-8680876.0,123782.0,,,,,,,,,,,,,,-2863.0,,,11972307.0,297462629.0,11909588.0,,,,,-8804658.0,3556322.0,,8650414.0,-8650414.0,,167757.0,64599.0,-30462.0,,,,,,,,0.0,0.0,8071586.0,,3980461.0,,,,,,,,,15654223.0,73476.0,,,,6700862.0,-27971306.0,,,,,,,,,6.97,,285490322.0,,264565421.0,,,189370.0,,,,0.0,,,57582025.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-12,10-Q,POINT BIOPHARMA GLOBAL INC.,PNT,CIK0001811764,USD,3218234.0,4674266.0,,253221.0,314117994.0,348117.0,,6178.0,277195916.0,259293937.0,,,252825718.0,252825718.0,,,,0.0001,430000000.0,90121794.0,90121794.0,9012.0,,,,62719.0,,,,,0.0,-0.19,,-0.19,,,,5486152.0,,,,1905.0,4026666.0,-17035588.0,81044.0,,,,,,,,,,,,,8590.0,-6178.0,,,8156848.0,277195916.0,8094129.0,0.0,,,,-17116632.0,,,17031315.0,-17031315.0,,173950.0,173061.0,-4273.0,,,,,,,,0.0,0.0,6468219.0,,3103769.0,,,,,,,,,17901979.0,161953.0,,,,13004649.0,-45087938.0,,,,0.0,0.0073,6.6e-05,,,,,269039068.0,,317261.0,,,201629.0,,,,0.0,,90121794.0,,90121794.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
